Keyphrases
Randomized Trial
100%
Chronic Hepatitis C
100%
Postmenopausal Women
100%
Raloxifene
100%
Antiviral Treatment
100%
Standard of Care
87%
IL28B
37%
Sustained Virological Response
37%
Response Rate
25%
Ribavirin
25%
Estrogen
12%
Polymorphism
12%
Treatment Group
12%
Gene-rich Regions
12%
Rash
12%
Chronic Hepatitis C Virus Infection
12%
Interleukin-28B Gene
12%
Genotype 1b
12%
Selective Estrogen Receptor Modulators
12%
Pegylated Interferon
12%
Early Menopause
12%
Treatment Standards
12%
Rs8099917
12%
Medicine and Dentistry
Antiviral Therapy
100%
Chronic Hepatitis C
100%
Raloxifene
100%
Postmenopause
100%
Interleukin 28B
50%
Patient Care
25%
Ribavirin
25%
Allele
12%
Exanthem
12%
Early Menopause
12%
Estrogen Release
12%
Selective Estrogen Receptor Modulator
12%
Peginterferon
12%
Nursing and Health Professions
Antiviral Therapy
100%
Chronic Hepatitis C
100%
Health Care Quality
100%
Raloxifene
100%
Interleukin 28B
50%
Ribavirin
25%
Peginterferon
12%
Early Menopause
12%
Selective Estrogen Receptor Modulator
12%
Rash
12%
Immunology and Microbiology
Interleukin 28B
100%
Postmenopause
100%
Hepatitis C
100%
Ribavirin
50%
Allele
25%
Pegylated Interferon
25%
Estrogen Release
25%
Early Menopause
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Chronic Hepatitis C
100%
Raloxifene
100%
Interleukin 28B
50%
Ribavirin
25%
Rash
12%
Selective Estrogen Receptor Modulator
12%
Early Menopause
12%
Peginterferon
12%